Black, RE., Cousens, S,, Johnson, HL., Lawn, JE., Rudan, I., Bassani, DG., 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. The lancet. 375 (9730), 1969-87.
Chovel, ML., Mandiarote, A., Ontivero, I., Mahy, T., Herrera, L., Núñez, JF., 2012. Development of 3Rs alternatives for determining potency and toxicity of vaccines in Cuba: current challenges and research projects in progress. ALTEX 29, 71-6.
Corbel, MJ., Xing, DK., 2004. Toxicity and potency evaluation of pertussis vaccines. Expert review of vaccines. 3(1), 89-101.
Hoonakker, M., Verhagen, L., van der Maas, L., Metz, B., Uittenbogaard, J., van de Waterbeemd, B., 2016. Adaptive immune response to whole cell pertussis vaccine reflects vaccine quality: A possible complementation to the Pertussis Serological Potency test. Vaccine. 34 (37), 4429-36.
Kendrick, PL., Eldering, G., Dixon, MK., Misner, J., 1947. Mouse protection tests in the study of pertussis vaccine: a comparative series using the intracerebral route for challenge. American Journal of Public Health and the Nations Health. 37 (7), 803-10.
Matos, DCS., Marcovistz, R., Silva, AMVd., Quintilio, W., Georgini, RA., 2012. Comparative analysis of the intracerebral mouse protection test and serological methodfor potency assays of pertussis component in DTP vaccine. Brazilian Journal of Microbiology. 43 (2), 429-31.
Van der Ark, A., van Straaten-van de Kappelle, I., Akkermans, A., Hendriksen, C., van de Donk, H., 1994. Development of Pertussis Serological Potency Test: Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model. Biologicals. 22 (3); 233-42.
Van der Ark, A., Van Straaten-van de Kappelle, I., Hendriksen, C., Van de Donk, H., 1995. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test. Developments in biological standardization. 86, 271-81.
Van der Ark, A., van Straaten-van de Kappelle, I., Hendriksen, C., 1998.Pertussis serological potency test as an alternative to the intracerebral mouse protection test: development, evaluation and validation. ALTEX. 15 (5), 33-6.
Van der Ark, A., van Straaten-van de Kappelle, I., Ölander, R-M., Enssle, K., Jadhav, S., Van de Donk, H., 2000. The pertussis serological potency test collaborative study to evaluate replacement of the mouse protection test. Biologicals. 28 (2), 105-18.
Van Straaten, I., Levels, L., van der Ark, A., Thalen, M., Hendriksen, C., 2001. Toxicity and
Immunogenicity of pertussis whole cell vaccine in one animal model. Developments in
biologicals. 111, 47-55.
Von Hunolstein, C., Gomez Miguel, M., Pezzella, C., Scopetti, F., Behr-Gross, M., Halder, M., 2008. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines. Pharmeuropa Bio 1, 7-18.
World Health Organization, WHO, 1990. Control of whole-cell pertussis vaccine, WHO Technical Report Series. No. 800, A.3.4. 133-138
World Health Organization, WHO, 2013. Manual for quality Control of Diphtheria, Tetanus and Pertussis vaccines. WHO/IVB/11.11. 175-190.